CITF-funded researchers Drs. Jeff Kwong from the University of Toronto, Gaston de Serres from l’Institut national de santé publique du Québec, and Mel Krajden of the University of British Columbia, found that two doses of mRNA or viral vector (Astra Zeneca) vaccines provide excellent protection against severe outcomes (hospitalization or death) from COVID-19.